Call Options

24 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $1.38 Million - $1.61 Million
-8,900 Reduced 16.51%
45,000 $7.72 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $6.95 Million - $7.92 Million
43,500 Added 418.27%
53,900 $9.82 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $564,160 - $635,377
4,100 Added 65.08%
10,400 $1.61 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $227,103 - $262,905
1,700 Added 36.96%
6,300 $939,000
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $7.54 Million - $9.38 Million
-56,900 Reduced 92.52%
4,600 $619,000
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $9.78 Million - $11.3 Million
-67,600 Reduced 52.36%
61,500 $9.8 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $15.9 Million - $19.1 Million
115,100 Added 822.14%
129,100 $20.9 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $9.49 Million - $10.9 Million
-70,700 Reduced 83.47%
14,000 $1.88 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $113 Million - $144 Million
-823,700 Reduced 90.68%
84,700 $13 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $146 Million - $181 Million
-1,106,600 Reduced 54.92%
908,400 $147 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $184 Million - $233 Million
1,712,600 Added 566.34%
2,015,000 $273 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $14.8 Million - $16.8 Million
139,400 Added 85.52%
302,400 $32.6 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $8.52 Million - $9.49 Million
81,000 Added 98.78%
163,000 $18.4 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $11 Million - $12.1 Million
-107,660 Reduced 56.76%
82,000 $8.87 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $2.56 Million - $3.46 Million
-31,800 Reduced 14.36%
189,660 $20.3 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $3.1 Million - $3.64 Million
-36,100 Reduced 14.02%
221,460 $19.4 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $14.6 Million - $19.6 Million
199,460 Added 343.3%
257,560 $25.3 Million
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $586,950 - $889,889
9,100 Added 18.57%
58,100 $4.43 Million
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $5.65 Million - $7.08 Million
-78,400 Reduced 61.54%
49,000 $4.34 Million
Q3 2019

Nov 08, 2019

BUY
$62.98 - $75.72 $5.76 Million - $6.92 Million
91,400 Added 253.89%
127,400 $9.51 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $2.29 Million - $2.92 Million
34,800 Added 2900.0%
36,000 $2.62 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $1.45 Million - $1.71 Million
-18,800 Reduced 94.0%
1,200 $97,000
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $1.17 Million - $1.44 Million
-15,000 Reduced 42.86%
20,000 $1.84 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $3.11 Million - $3.46 Million
35,000 New
35,000 $3.31 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.